JNCE insider trading

Jounce Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
167
Last 90 days
0
Buys / sells
4% / 53%
Market cap
—

JNCE insider activity at a glance

FilingIQ tracks 167 insider transactions for JNCE in filings since Feb 1, 2017. The most recent transaction is dated May 3, 2023.

Across the full history, 6 open-market purchases and 89 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on JNCE insider trades is 56.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest JNCE Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for JNCE?
FilingIQ tracks 167 Form 4 insider transactions for JNCE (Jounce Therapeutics, Inc.), covering filings from Feb 1, 2017 onwards. 0 of those are dated within the last 90 days.
Are JNCE insiders net buyers or net sellers?
Across the full Form 4 history for JNCE, 6 transactions (4%) were open-market purchases and 89 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does JNCE insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every JNCE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.